Alle afleveringen
364 afleveringen, van nieuw naar oud
-
How a once-weekly insulin could disrupt diabetes management
22 september 2022 · 17 min
In the latest pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah Comstock to talk about the innovative once-weekly insulin currently in development and how it could change the game for people currently managing their type 2 diabetes with daily injections. Lees meer
-
How these parents of a child with a rare disease are making precision medicine work for them
8 september 2022 · 31 min
In today’s pharmaphorum podcast, editor in chief Jonah Comstock invites Drs Zachary and Geri Landman to tell their daughter Lucy’s story and the story of their new nonprofit Moonshots for Unicorns, which sets up a framework for parents in their circumstance to directly crowdfund research for rare single-gene disorders – starting with PGAP3. Lees meer
-
AI-derived cancer vaccines
25 augustus 2022 · 20 min
Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. Lees meer
-
Challenges and opportunities in the off-patent sector
11 augustus 2022 · 25 min
In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at Sandoz. Lees meer
Rebecca speaks about generics and biosimilars: what they are, why they’re important for medication access and healthcare cost sustainability, and what Sandoz has learned about succeeding in the off-patent world. She also touches on the patient stories behind the headlines and the effect of COVID-19 on the generics market.
-
Building a digital therapeutic for paediatric behavioural health opioids
28 juli 2022 · 22 min
On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Dr Benny Alouf, chief medical officer at Limbix to discuss his company’s digital therapeutic for teen depression.
-
Gene silencing and mRNA: breakthroughs and barriers
14 juli 2022 · 23 min
On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular design at Silence Therapeutics.
-
Rethinking pharmaceutical pain management beyond opioids
5 juli 2022 · 22 min
On the latest installment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio.
-
Why diverse clinical trials matter
16 juni 2022 · 27 min
In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials.
-
Where pharma stands on patient centricity, engagement, and trust
6 juni 2022 · 27 min
In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock catches up with Pervaise Khan, Managing Director of Life Sciences, UK and Ireland, Accenture.
-
How pharma can spur innovation and promote health equity in mental health
19 mei 2022 · 25 min
In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, Vice President of Commercial at US Janssen Neuroscience.
-
Innovative solutions to the drug pricing crisis: the pharmaphorum podcast
29 april 2022 · 24 min
In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst. Lees meer
They discuss out of control drug pricing, especially in the United States, that has led to nonadherence and care rationing
-
Big data and how it can change the game in pharma: the pharmaphorum podcast
23 maart 2022 · 31 min
In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet - before joining COTA last year, she headed up J&J’s Clinical Trial Feasibility and Advanced Analytics Team and led the Digital Health and Innovation Team at Bristol Myers Squibb. Lees meer
-
The year ahead in digital health and life sciences: the pharmaphorum podcast
10 februari 2022 · 27 min
In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe). Lees meer
Tune in to hear about the year ahead in digital health and life sciences, as well as the need for partnership and collaboration more broadly between the pharma and tech worlds. Goldsack reports on what she heard in the virtual events surrounding JP Morgan this year, and then puts some of those insights into context out of her own experience.
-
The evolution of clinical trials: the pharmaphorum podcast
14 januari 2022 · 44 min
In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo Health Research vice president, strategic partnerships, Keith Fern. Lees meer
Together they discuss the changing nature of clinical trials how COVID-19 impacted the sector, and the role technology is playing in supporting trial enrolment and retention.
-
Patient engagement processes: the pharmaphorum podcast
17 december 2021 · 41 min
This episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s being led clinician, consultant and patient advocate, Mark Duman.
-
Real-world evidence and qualitative research: the ELICIT podcast
25 november 2021 · 21 min
In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the guests discuss qualitative real-world evidence and a unique dementia project from Singapore.
-
Merck on trends in oncology: the pharmaphorum podcast
12 november 2021 · 18 min
Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the most potential to improve patient outcomes.
-
Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast
5 november 2021 · 19 min
In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars.
-
Patient engagement strategies: the pharmaphorum podcast
29 oktober 2021 · 34 min
This episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s being led by Mark Duman, a clinician, consultant and patient advocate.
-
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast
15 oktober 2021 · 26 min
Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications.
-
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast
4 oktober 2021 · 25 min
Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.
-
Virtual engagement and collaborations: the pharmaphorum podcast
22 september 2021 · 28 min
As the world passes the year and a half mark of the COVID-19 pandemic, the evolving experience of the ‘new normal’ environment across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals.
-
Biotech Insight podcast: Overcoming planning challenges in oncology
8 september 2021 · 14 min
The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology.
-
Vertex senior country manager Nicola Massey: the pharmaphorum podcast
23 augustus 2021 · 23 min
In the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland.
-
Regenerative medicine and COVID: the pharmaphorum podcast
13 augustus 2021 · 15 min
In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine.
-
Pharmacy and clinical research: the pharmaphorum podcast
30 juni 2021 · 36 min
In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2. Lees meer
The US-based company was founded in 2019 and is on a mission to bring the practice of pharmacy into clinical research.
-
Pharma’s post-COVID prospects: the pharmaphorum podcast
28 mei 2021 · 14 min
In this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year’s Q1 results season.
-
Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast
30 april 2021 · 17 min
Episode 35 of the pharmaphorum podcast heard from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit.
-
Big data and cell therapy development: the pharmaphorum podcast
20 april 2021 · 1 uur 2 min
In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr. Darrin Disley, CEO of UK biotech Mogrify
-
GSK on COVID and vaccine development: the pharmaphorum podcast
31 maart 2021 · 20 min
In the latest episode of the podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandemic.
-
The meaning of digital innovation: the pharmaphorum podcast
23 maart 2021 · 24 min
This instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, and features digital transformation leader Edwin Erckens.
-
New ways to treat COVID: the pharmaphorum podcast
12 maart 2021 · 20 min
In episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business officer Guy Goldberg about the potential for new COVID-19 therapeutics to help fight the pandemic and treat patients in the years to come. Lees meer
-
The Alderley Park Discovery Podcast: The journey to accessing science funding and investment
8 maart 2021 · 36 min
Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors. Lees meer
In this instalment, Dominic Tyer is joined by Kinomica CEO Jane Theaker, BioCity investment director Claire Brown, Redx Pharma CEO Lisa Anson and Dr Kath Mackay, managing director at Bruntwood SciTech - Alderley Park.
-
Roche on COVID healthcare and testing: the pharmaphorum podcast
26 februari 2021 · 19 min
For episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Ireland at Roche Diagnostics, about the pressure COVID-19 has put on healthcare systems. Lees meer
A former NHS doctor, he noted how stressful and draining some days can be when working at healthcare’s frontline - even in normal times, and that the current fight against the pandemic brings little respite to staff.
-
Richard Francis discusses his new role as Purespring’s CEO: pharmaphorum podcast
12 februari 2021 · 14 min
In this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took over as CEO of gene therapy company Purespring Therapeutics earlier this month. Lees meer
Francis was previously CEO of Sandoz, Novartis’ generics and biosimilars division, where he led the development of biosimilars and also sat on the Swiss pharma company’s executive committee.
-
AstraZeneca’s Rebekah Martin on diversity and inclusion: the pharmaphorum podcast
29 januari 2021 · 24 min
The theme for episode 28 of the pharmaphorum podcast is diversity and inclusion in pharma, ably addressed by AstraZeneca’s Rebekah Martin. Lees meer
Serving as senior vice president of reward and inclusion at AstraZeneca, Rebekah discussed how the pharmaceutical industry approaches the promotion of diversity.
In an episode that was recorded in December 2020, she also talked about what inclusion and diversity mean to her company.
-
The Alderley Park Discovery Podcast: Life science skills, staffing and support
5 januari 2021 · 38 min
Episode two of the Alderley Park Discovery Podcast covers access to skills in the life sciences sector, with a focus on support for aspiring scientists and UK staffing trends. Lees meer
In this instalment Dominic Tyer’s guests on the podcast are Sai Life Sciences’ head of global R&D Dean Edney, Joynes & Hunt’s managing director Steve Joynes and Dr Kath Mackay, managing director at Bruntwood SciTech’s Alderley Park.
-
J&J and medical device innovation: the pharmaphorum podcast
21 december 2020 · 17 min
In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU Regional Vice President at J&J Surgical Vision. Lees meer
She talks about her priorities at J&J, having joined the company six months ago, the current state of the medical devices sector and some of the trends she’s keeping a close eye on.
-
Biotech trends in COVID era: the pharmaphorum podcast
30 november 2020 · 18 min
In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.
-
GSK and eosinophil research: the pharmaphorum podcast
30 oktober 2020 · 13 min
GlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Syndrome (HES). Lees meer
It’s part of the company’s focus on eosinophil-driven diseases and ahead of that regulatory milestone I spoke with Tiffany Robinson-Smith, who’s global medical affairs lead for biologics at GSK, about eosinophils and why they’re an important element of her company’s research programmes.
-
Gitte Aabo on telemedicine and her time at LEO Pharma: the pharmaphorum podcast
28 september 2020 · 16 min
In this episode of the podcast Gitte discusses telemedicine, GN Hearing’s work in this area – and the impact of COVID-19, plus her time at LEO Pharma.
-
The Alderley Park Discovery Podcast: COVID testing and the Lighthouse Lab
15 september 2020 · 23 min
The Alderley Park Discovery Podcast, produced in partnership with pharmaphorum, presents perspectives on UK and global bioscience innovation trends, with input from key experts including managing director and leader of Bruntwood SciTech’s Alderley Park Dr Kath Mackay. Lees meer
-
Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast
27 augustus 2020 · 19 min
Anlnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route to target the current coronavirus pandemic.
-
Novartis, company culture and COVID-19: the pharmaphorum podcast
30 juli 2020 · 20 min
Novartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face
-
Amgen and science education: the pharmaphorum podcast
30 juni 2020 · 22 min
Harvard University launched LabXchange in January and the free science education platform has acquired new resonance during the
-
UK pharma leadership and COVID-19: the pharmaphorum podcast
29 mei 2020 · 21 min
The COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure
-
Eisai and Alexa skills in epilepsy: the pharmaphorum podcast
2 april 2020 · 14 min
Voice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world
-
Digital health and interoperability: the pharmaphorum podcast
9 maart 2020 · 21 min
One of the biggest barriers to applying precision medicine to clinical trials and patient engagement is getting different
-
Roche, big data and patient outcomes: the pharmaphorum podcast
8 januari 2020 · 32 min
In the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data
-
Pfizer and the UK cancer landscape: the pharmaphorum podcast
11 december 2019 · 29 min
Pfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK